A crispr/cas9-based assay for high-throughput studies of cancer-induced innervation

HIGHLIGHTS

• who: Sapthala Loku Galappaththi and colleagues from the Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL, USA have published the research: A CRISPR/Cas9-Based Assay for High-Throughput Studies of Cancer-Induced Innervation, in the Journal: Cancers 2023, 15, x FOR PEER REVIEW of 22/02/2023
• what: The approach demonstrated that gene editing did not affect neuronal behavior and enabled accurate reporting of cancer-induced neuronal differentiation dynamics in high-throughput settings which makes this approach suitable for screening large cohorts of cells or testing various . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.